4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001415889-25-002160
CHIEF COMMERCIAL OFFICER sold 14,754 shares at an average $37.38 ($551,575)
- CHIEF COMMERCIAL OFFICER acquired 15,812 shares (option exercise)
- CHIEF COMMERCIAL OFFICER gave up 1,058 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Option exercise 10b5-1 | +13,125 | $30.69 | $402,806 | 13,125 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Sale 10b5-1 | −8,000 | $36.94 | $295,531 | 5,125 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Sale 10b5-1 | −5,125 | $37.87 | $194,103 | 0 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Option exercise 10b5-1 | +2,687 | 2,687 | D | ||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Shares withheld for taxes 10b5-1 | −1,058 | $38.01 | $40,215 | 1,629 | D |
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-27 | Sale 10b5-1 | −1,629 | $38.02 | $61,941 | 0 | D |
| Derivatives | |||||||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Option exercise · Stock Option 10b5-1 | −13,125 | 39,375 | D | ||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-24 | Option exercise · Restricted Stock Units 10b5-1 | −2,687 | 8,063 | D | ||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-25 | Grant or award · Stock Option 10b5-1 | +47,200 | 47,200 | D | ||
| Dierks Jeffrey CHIEF COMMERCIAL OFFICER | 2025-01-25 | Grant or award · Restricted Stock Units 10b5-1 | +13,450 | 13,450 | D | ||
| Open-market sales · 14,754 sh · avg $37.38 · $551,575 | |||||||
Loading xslF345X05/form4-01282025_090140.xml…